IndraLab

Statements


KCNH2 activates Long QT Syndrome type 2. 2 / 2
| 2

reach
"Rare mutations in KCNH2, a potassium channel involved in myocardial repolarization and drug induced arrhythmias, are known to underlie congenital Long QT Syndrome type 2 and Short QT Syndrome type 1."

reach
"Long QT Syndrome type 2 (LQT2) is caused by mutations in the KCNH2 gene that encodes for the alpha-subunit (hERG) of the ion channel conducting the rapid delayed rectifier potassium current (I Kr)."